HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas Berg Selected Research

Interferon-alpha (Interferon Alfa)

1/2021Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression.
1/2021Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B.
1/2015Sadness and mild cognitive impairment as predictors for interferon-alpha-induced depression in patients with hepatitis C.
10/2014Extended treatment with pegylated interferon alfa/ribavirin in patients with genotype 2/3 chronic hepatitis C who do not achieve a rapid virological response: final analysis of the randomised N-CORE trial.
1/2014Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.
1/2014PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C.
6/2013Delayed versus immediate treatment for patients with acute hepatitis C: a randomised controlled non-inferiority trial.
1/2012A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis C.
12/2011The determination of GGT is the most reliable predictor of nonresponsiveness to interferon-alpha based therapy in HCV type-1 infection.
9/2011IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas Berg Research Topics

Disease

106Infections
01/2022 - 01/2003
76Fibrosis (Cirrhosis)
01/2022 - 01/2003
71Chronic Hepatitis C
01/2022 - 12/2002
54Hepatitis C
01/2022 - 08/2003
45Chronic Hepatitis B
04/2022 - 06/2005
37Hepatocellular Carcinoma (Hepatoma)
09/2022 - 01/2003
36Liver Diseases (Liver Disease)
01/2022 - 06/2002
34Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 11/2007
27Hepatitis B
04/2022 - 06/2002
17Inflammation (Inflammations)
11/2022 - 02/2005
15Neoplasms (Cancer)
09/2022 - 01/2003
13Hepatitis
01/2021 - 09/2005
11Non-alcoholic Fatty Liver Disease
01/2022 - 08/2010
11Viremia
03/2013 - 08/2003
10Virus Diseases (Viral Diseases)
01/2021 - 04/2008
8Disease Progression
01/2021 - 08/2004
8Bell Palsy (Bell's Palsy)
01/2015 - 11/2008
7Fatty Liver
05/2022 - 09/2002
7Alcoholic Liver Diseases (Alcoholic Liver Disease)
01/2020 - 01/2008
6Ascites
10/2022 - 05/2014
6Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2022 - 09/2006
6End Stage Liver Disease
01/2022 - 01/2017
6Alcoholic Liver Cirrhosis (Alcoholic Cirrhosis)
11/2019 - 04/2008
5Liver Failure
01/2022 - 06/2005
5Mental Disorders (Mental Disorder)
01/2021 - 06/2005
5Persistent Infection
01/2021 - 02/2006
5Reinfection
01/2019 - 06/2002
4Acute-On-Chronic Liver Failure
11/2022 - 01/2021
4Intrahepatic Cholestasis
02/2022 - 10/2013
4Fatigue
01/2022 - 08/2007
4COVID-19
01/2022 - 06/2020
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 07/2011
4Anemia
11/2011 - 07/2006
3Cholangiocarcinoma
07/2022 - 10/2014
3Coinfection
04/2022 - 11/2008
3Chronic Hepatitis (Chronic Active Hepatitis)
04/2022 - 11/2018
3Liver Neoplasms (Liver Cancer)
02/2022 - 09/2010
3Sclerosing Cholangitis
01/2022 - 10/2014
3Headache (Headaches)
01/2022 - 11/2007
3Dental Caries (Decay, Dental)
03/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

72Antiviral Agents (Antivirals)IBA
01/2022 - 06/2002
41Ribavirin (Virazole)FDA LinkGeneric
01/2021 - 12/2002
30InterferonsIBA
01/2021 - 12/2002
27Interferon-alpha (Interferon Alfa)IBA
01/2021 - 12/2002
21DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2004
20Tenofovir (Viread)FDA Link
04/2022 - 08/2002
20Hepatitis B e AntigensIBA
01/2022 - 06/2005
16Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2022 - 06/2005
14RNA (Ribonucleic Acid)IBA
01/2021 - 03/2003
13EnzymesIBA
01/2022 - 09/2002
12Biomarkers (Surrogate Marker)IBA
09/2022 - 11/2007
12entecavirFDA Link
01/2022 - 01/2011
10Alanine Transaminase (SGPT)IBA
01/2022 - 01/2011
10Lamivudine (Epivir)FDA Link
07/2019 - 08/2002
9AntigensIBA
01/2022 - 10/2006
9CytokinesIBA
03/2021 - 08/2006
8LipidsIBA
01/2021 - 11/2010
8Proteins (Proteins, Gene)FDA Link
11/2019 - 08/2006
8peginterferon alfa-2b (Pegintron)FDA Link
06/2013 - 07/2006
7Granulocyte Colony-Stimulating Factor (G-CSF)IBA
11/2022 - 07/2006
7NucleosidesIBA
01/2022 - 01/2010
7SofosbuvirIBA
11/2019 - 02/2014
7Prednisolone (Predate)FDA LinkGeneric
01/2018 - 11/2008
6AntibodiesIBA
01/2022 - 09/2006
6NucleotidesIBA
01/2017 - 09/2009
5Interleukin-6 (Interleukin 6)IBA
02/2022 - 08/2006
5nasIBA
10/2021 - 08/2010
5Transaminases (Aminotransferases)IBA
01/2021 - 01/2011
5LigandsIBA
01/2016 - 11/2009
5Protease Inhibitors (Protease Inhibitor)IBA
05/2014 - 06/2011
5adefovirIBA
04/2014 - 12/2004
5Messenger RNA (mRNA)IBA
05/2013 - 02/2008
4gadolinium ethoxybenzyl DTPAFDA Link
09/2022 - 01/2020
4AcyltransferasesIBA
01/2022 - 01/2017
4Ursodeoxycholic Acid (Urso)FDA LinkGeneric
03/2021 - 08/2010
4ChemokinesIBA
01/2021 - 08/2004
4Pharmaceutical PreparationsIBA
01/2021 - 05/2008
4paritaprevirIBA
11/2019 - 05/2014
4MicroRNAs (MicroRNA)IBA
01/2019 - 01/2011
4ombitasvirIBA
11/2018 - 05/2014
4Mycophenolic Acid (Cellcept)FDA LinkGeneric
05/2018 - 12/2002
4Adrenal Cortex Hormones (Corticosteroids)IBA
05/2018 - 11/2008
4peginterferon alfa-2a (Pegasys)FDA Link
01/2018 - 06/2005
4Interferon LambdaIBA
10/2017 - 04/2010
4Emtricitabine (Emtriva)FDA Link
01/2017 - 10/2010
4adefovir dipivoxil (Hepsera)FDA Link
01/2011 - 12/2004
4Amantadine (Aman)FDA LinkGeneric
11/2008 - 06/2003
3AlbuminsIBA
02/2022 - 08/2018
3InterleukinsIBA
02/2022 - 01/2013
3CholesterolIBA
01/2022 - 11/2010
3gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2022 - 01/2020
3glecaprevir and pibrentasvirIBA
01/2022 - 01/2019
3Anti-Bacterial Agents (Antibiotics)IBA
01/2021 - 01/2017
3Methionine (L-Methionine)FDA Link
01/2021 - 11/2010
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
12/2020 - 04/2012

Therapy/Procedure

98Therapeutics
07/2022 - 12/2002
47Liver Transplantation
01/2022 - 06/2002
7Transplantation
01/2022 - 01/2003
4Aftercare (After-Treatment)
03/2021 - 02/2007
4Retreatment
01/2021 - 11/2011